Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 5
2004 5
2005 5
2006 9
2007 10
2008 10
2009 14
2010 24
2011 24
2012 24
2013 32
2014 37
2015 42
2016 30
2017 50
2018 57
2019 60
2020 70
2021 16
Text availability
Article attribute
Article type
Publication date

Search Results

464 results
Results by year
Filters applied: . Clear all
Page 1
Hepatology Highlights.
Trivedi HD, Lau DTY, Kulai TB, Malhi H, Schwartz RE, Pisa JF, Brown RS Jr, Russo N, Nair KM, Roccaro G, Hirsova P, Gupta V, Xu X, Krisko T, Kostallari E. Trivedi HD, et al. Among authors: xu x. Hepatology. 2019 May;69(5):1849-1851. doi: 10.1002/hep.30634. Hepatology. 2019. PMID: 30977535 No abstract available.
Hepatology Highlights.
Mousa O, Malhi H, Schwartz RE, Kulai TB, Trivedi HD, Lau DTY, Shen NT, Brown RS Jr, Hirsova P, Xu X, Nicholls HT, Pisa JF, Tafesh ZH, Fortune BE, Gupta V, Kostallari E, Russo N, Jesudian AB. Mousa O, et al. Among authors: xu x. Hepatology. 2019 Mar;69(3):927-930. doi: 10.1002/hep.30569. Hepatology. 2019. PMID: 30811657 No abstract available.
Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug Treatment.
Clemens PL, Yan X, Lokhorst HM, Lonial S, Losic N, Khan I, Jansson R, Ahmadi T, Lantz K, Zhou H, Puchalski T, Xu XS. Clemens PL, et al. Clin Pharmacokinet. 2017 Aug;56(8):915-924. doi: 10.1007/s40262-016-0477-1. Clin Pharmacokinet. 2017. PMID: 27896689 Free PMC article. Clinical Trial.
Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses.
Xu XS, Moreau P, Usmani SZ, Lonial S, Jakubowiak A, Oriol A, Krishnan A, Bladé J, Luo M, Sun YN, Zhou H, Nnane I, Deraedt W, Qi M, Ukropec J, Clemens PL. Xu XS, et al. Adv Ther. 2020 Apr;37(4):1464-1478. doi: 10.1007/s12325-020-01247-8. Epub 2020 Feb 20. Adv Ther. 2020. PMID: 32078124 Free PMC article. Clinical Trial.
FNDC5/Irisin inhibits pathological cardiac hypertrophy.
Yu Q, Kou W, Xu X, Zhou S, Luan P, Xu X, Li H, Zhuang J, Wang J, Zhao Y, Xu Y, Peng W. Yu Q, et al. Among authors: xu x. Clin Sci (Lond). 2019 Mar 1;133(5):611-627. doi: 10.1042/CS20190016. Print 2019 Mar 15. Clin Sci (Lond). 2019. PMID: 30782608
464 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page